Episodes

For millennia, humans have believed that aging is inevitable. Yet thirty years ago, the work of Professor Cynthia Kenyon and her colleagues showed that a single gene mutation in a worm doubled its lifespan and postponed the diseases of aging. …

What is a thought? Some may think that question is quite abstract, but it has huge implications for science and computer design.

Psychiatry is changing and will be unrecognizable in the next 10-20 years, given our new understanding about the role of brain circuits in the generation of emotions and behavior. This week we talk to Professor Karl Deisseroth, D.H. Chen Professor …

This week we speak with Professor David Baker about the enormous scope for making new proteins and how that translates into practical uses to tackle diseases, such as Covid-19.

In the last 20 years or so, many new cancer treatments have emerged that provide greater precision and targeting of cancer cells. Today, we have a better understanding of the genetic components of cancer. Through novel technology and cutting-edge science, …

Genome editing holds the potential to be a transformative new therapy, and the pace of progress is truly breathtaking.

In this episode we explore the vastness of the dark genome and why "junk DNA" has been overlooked for so many decades.

Julia Vitarello is the mother of Mila Makovec, and the Founder and CEO of Mila’s Miracle Foundation.

Aviv Regev is a computational biologist and Executive Vice President of Genentech Research and Early Development. She was professor at the Broad Institute of MIT and Harvard and at the Department of Biology of the Massachusetts Institute of Technology, as …

Dr. Amy Abernethy is an oncologist, specialist in palliative care medicine, researcher, previous Professor of Medicine at Duke University School of Medicine, previous Scientific and Medical Chief Officer of Flatiron Health, and previous Principal Deputy Commissioner of the FDA.

David Altshuler is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals.

Dr. Timothy Yu walks us through his experience running the first "N of 1" drug trial for a young patient with a devastating genetic mutation.

Dr. Krishna Yeshwant is Managing Partner at GV, and a practicing physician at Brigham and Women’s Hospital in Boston.

Theory and Practice speaks with Dr. Caroline Uhler, currently the Henry L. and Grace Doherty associate professor in EECS (Electrical Engineering & Computer Science) and IDSS (Institute for Data, Systems and Society) at MIT, and associate member of the Broad …

Theory and Practice speaks with Professor Jennifer Listgarten, Professor in UC Berkeley's Electrical Engineering and Computer Sciences Department (EECS department) and the Center for Computational Biology, and Chan Zuckerberg investigator.

Theory and Practice speaks with Professor Sir Rory Collins, Head of Nuffield Department of Population Health at Oxford University and BHF (British Heart Foundation) Professor of Medicine and Epidemiology. Professor Collins is also Principal Investigator and Chief Executive of the …

Dr. Anne Carpenter is the inventor of CellProfiler and designed a method for coloring and analyzing cells. She works at the Broad Institute as the Senior Director of the Imaging Platform and is an Institute Scientist.

One week until Theory and Practice returns! Join Anthony and Alex as they discuss cutting-edge health developments with leaders in biology and computer science.

The hosts interview a panel of distinguished guests, including life sciences entrepreneur and investor Alexis Borisy, Finale Doshi-Velez of Harvard University's John A. Paulson School of Engineering and Applied Sciences, and Pardis Sabeti of the Broad Institute of MIT and …

Zach Weinberg is the co-founder, president, and COO of Flatiron Health. He discusses his entrepreneurial journey and Flatiron Health's approach to accelerating cancer care and improving patient outcomes.

Cori Bargmann is the head of science at the Chan Zuckerberg Initiative. She is also the head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior and the Torsten N. Wiesel Professor at The Rockefeller University in …

Professor Daphne Koller is the CEO and founder of insitro. She joins the podcast to discuss how machine learning and biology can advance drug discovery and patient care.

David Sontag, Associate Professor of Electrical Engineering and Computer Science at MIT, explores how artificial intelligence can transform medicine, and discusses the importance of fairness in machine learning.

Eric Lander, president and founding director of the Broad Institute of MIT and Harvard, joins the show to discuss human genetics and computational biology.